According to the foreign news agency Reuters, this development paves the way for large-scale vaccination of the Russian population while the final phase of clinical trials to test safety and efficacy is underway.
The pace at which Russia is developing its own vaccine demonstrates its determination to win the global race for an effective product, but there are still concerns that national dignity may be put ahead of science and safety.
Addressing the official meeting, the Russian president said the vaccine was developed by the Gamaliya Institute in Moscow and was safe and had even been given to his daughter.
"I know it works very well, builds strong immunity and I repeat it has passed all the required tests.
He said he hoped the country would soon start mass production of the vaccine.
With its approval by the Ministry of Health, a large trial involving thousands of participants is predicted to begin, commonly known as the Phase 3 trial.
Such trials are generally considered a prerequisite for a vaccine to receive formal approval.
At a certain rate, people are exposed to the virus in order to see the effect of the vaccine.
Regulators around the world have insisted that safety should not be compromised in the rapid development of the corona virus vaccine, but a recent survey showed growing public distrust in governments' efforts to develop such a vaccine. Has gone
A source told Reuters last month that Russian health workers would be given the opportunity to voluntarily vaccinate after treating Corona patients.
More than 100 possible vaccines are being developed around the world to try to control the corona virus.
At least four vaccines are in human testing in the final phase, Phase 3, according to WHO data.
